Emond B - Search Results

1

Incidence of cardiometabolic outcomes among people living with HIV-1 initiated on integrase strand transfer inhibitor versus non-integrase strand transfer inhibitor antiretroviral therapies: a retrospective analysis of insurance claims in the United States.

Rebeiro PF, Emond B, Rossi C, Bookhart BK, Shah A, Caron-Lapointe G, Lafeuille MH, Donga P. Rebeiro PF, et al. Among authors: emond b. J Int AIDS Soc. 2023 Jun;26(6):e26123. doi: 10.1002/jia2.26123. J Int AIDS Soc. 2023. PMID: 37306118 Free PMC article.

2

Comparison of Medicaid spending in schizoaffective patients treated with once monthly paliperidone palmitate or oral atypical antipsychotics.

Xiao Y, Muser E, Fu DJ, Lafeuille MH, Pilon D, Emond B, Wu A, Duh MS, Lefebvre P. Xiao Y, et al. Among authors: emond b. Curr Med Res Opin. 2016;32(4):759-69. doi: 10.1185/03007995.2016.1140634. Epub 2016 Feb 2. Curr Med Res Opin. 2016. PMID: 26750639

3

An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices.

Ma E, Bonthapally V, Chawla A, Lefebvre P, Swords R, Lafeuille MH, Fortier J, Emond B, Duh MS, Dezube BJ. Ma E, et al. Among authors: emond b. Clin Lymphoma Myeloma Leuk. 2016 Nov;16(11):625-636.e3. doi: 10.1016/j.clml.2016.08.006. Epub 2016 Aug 10. Clin Lymphoma Myeloma Leuk. 2016. PMID: 27686689 Free article.

4

Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic.

Pilon D, Joshi K, Tandon N, Lafeuille MH, Kamstra RL, Emond B, Lefebvre P. Pilon D, et al. Among authors: emond b. Patient Prefer Adherence. 2017 Mar 23;11:619-629. doi: 10.2147/PPA.S127623. eCollection 2017. Patient Prefer Adherence. 2017. PMID: 28356723 Free PMC article.

5

Quality measure and weight loss assessment in patients with type 2 diabetes mellitus treated with canagliflozin or dipeptidyl peptidase-4 inhibitors.

Wysham CH, Lefebvre P, Pilon D, Ingham M, Lafeuille MH, Emond B, Kamstra R, Chow W, Pfeifer M, Duh MS. Wysham CH, et al. Among authors: emond b. BMC Endocr Disord. 2017 Jun 8;17(1):32. doi: 10.1186/s12902-017-0180-8. BMC Endocr Disord. 2017. PMID: 28595617 Free PMC article.

6

Baseline characteristics and treatment patterns of patients with schizophrenia initiated on once-every-three-months paliperidone palmitate in a real-world setting.

Joshi K, Lafeuille MH, Brown B, Wynant W, Emond B, Lefebvre P, Tandon N. Joshi K, et al. Among authors: emond b. Curr Med Res Opin. 2017 Oct;33(10):1763-1772. doi: 10.1080/03007995.2017.1359516. Epub 2017 Aug 4. Curr Med Res Opin. 2017. PMID: 28741387

7

Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.

Pilon D, Tandon N, Lafeuille MH, Kamstra R, Emond B, Lefebvre P, Joshi K. Pilon D, et al. Among authors: emond b. Clin Ther. 2017 Oct;39(10):1972-1985.e2. doi: 10.1016/j.clinthera.2017.08.008. Epub 2017 Sep 15. Clin Ther. 2017. PMID: 28919292 Free article.

8

Real-world evaluation of Hba1c, blood pressure, and weight loss among patients with type 2 diabetes mellitus treated with canagliflozin: an analysis of electronic medical records from a network of hospitals in Florida.

Tanton D, Duh MS, Lafeuille MH, Lefebvre P, Pilon D, Zhdanava M, Emond B, Inman D, Bailey RA. Tanton D, et al. Among authors: emond b. Curr Med Res Opin. 2018 Jun;34(6):1099-1115. doi: 10.1080/03007995.2018.1444591. Epub 2018 Mar 5. Curr Med Res Opin. 2018. PMID: 29468896

9

HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.

Wysham CH, Pilon D, Ingham M, Lafeuille MH, Emond B, Kamstra R, Pfeifer M, Lefebvre P. Wysham CH, et al. Among authors: emond b. Endocr Pract. 2018 Mar;24(3):273-287. doi: 10.4158/EP-2017-0066. Endocr Pract. 2018. PMID: 29547044

10

Quality goal attainment and maintenance in patients with type II diabetes mellitus initiated on canagliflozin or a glucagon-like peptide-1 receptor agonist in an actual practice setting.

Wysham CH, Pilon D, Ingham M, Lafeuille MH, Emond B, Kamstra R, Pfeifer M, Lefebvre P. Wysham CH, et al. Among authors: emond b. Curr Med Res Opin. 2018 Jun;34(6):1125-1133. doi: 10.1080/03007995.2018.1454417. Epub 2018 Mar 27. Curr Med Res Opin. 2018. PMID: 29557199

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page